EraGen Biosciences and Applied BioCode said this week that they have entered into a strategic partnership and license agreement to develop and commercialize highly multiplexed molecular diagnostic tests.

Under the agreement, EraGen receives access to Applied BioCode's barcoded magnetic bead technology and CE-Marked BioCode-1000 system, which EraGen will couple with its MultiCode-PLx assays for analyzing nucleic acid targets in infectious disease and genetic testing for clinical laboratories, the companies said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.